Market cap
$38.7m
End-of-day close multiplied by current shares on issue.
BRW · NZX
Bremworth is an NZX-listed consumer / home furnishings company. Its latest covered result is FY26, with HY22 - FY26 of source-backed result history on Annolyse.
Latest result
FY26, released 31 August 2026
| Metric | Value | Change |
|---|---|---|
| Revenue | $106.8m | ↑ +20.2% |
| EBITDA | -$8.3m | ↓ -145.3% |
| NPAT | -$11.4m | ↓ -162.6% |
| Operating cash flow | -$8.3m | ↓ -152.4% |
| OCF / EBITDA % | 98.9% | ↑ +13.4pp |
| Net debt | -$22m | — |
| Net debt / EBITDA | 2.64x | — |
| ROE % | -18.8% | ↓ -44.0pp |
| DPS | 0.0c | — |
| PBT | -$11.2m | ↓ -160.2% |
Source: latest published briefing (FY26, released 31 August 2026). Change compares against the prior equivalent period: FY25, released 1 September 2025.
Valuation
Trailing P/E, EV/EBITDA, price-to-book and price-to-free-cash-flow ratios combine the latest available close with filing data. They are comparative measures, not forecasts or recommendations.
The latest close and share count context for the market price.
Market cap
$38.7m
End-of-day close multiplied by current shares on issue.
How the market price compares with recent earnings and cash-flow inputs.
P/E
Not available
Not meaningful when recent earnings are negative.
EPS
-0.17
Recent filing-derived earnings per share.
PEG
Not available
Not available for this company right now.
EV/EBITDA
Not available
Not meaningful when recent EBITDA is negative.
P/FCF
Not available
Not meaningful when free cash flow is negative or unavailable.
P/B
0.64x
Market value compared with latest reported equity.
Yield and investment-company valuation where supported.
Dividend yield
0.0%
Trailing dividends compared with the latest close.
Total return
Not available
Available once dividend and adjustment data are verified.
Daily closes use the full available width, with hover and touch values for each observation. Expand the chart to see more detail.
Five years of daily closes, as at close, 5 June 2026. Weekends, suspensions, and listing gaps stay as natural gaps in the time scale.
Filing-period markers only: EOD close on or before each release date divided by filing-derived trailing NPAT where both inputs verify.
Chat
Ask follow-up questions about Bremworth's latest result and company history.
Informational only. No buy, sell, hold, price-target, or personal financial advice.
Informational only. No buy, sell, hold, price-target, or personal financial advice.
Financial history
The latest period is shown first.
| Metric | FY2612 MONTHS31 August 2026 | FY2512 MONTHS1 September 2025 | HY256 MONTHS28 February 2025 | FY2412 MONTHS29 August 2024 | HY246 MONTHS29 February 2024 | FY2312 MONTHS1 March 2023 | FY2212 MONTHS30 September 2022 | HY226 MONTHS25 February 2022 | Trend |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $106.8m | $88.9m | $42.1m | $80.3m | $39m | $47.2m | $95.5m | $48.7m | Chart |
| Revenue growth % | 20.8%Unprecedented high revenue growth. 20.8%; 4-period range -14.4% to 10.7%. Revenue growth: 20.8%, unprecedented high; 4-period mean -4.3%, range -14.4%-10.7%. | 10.7%Outside range high revenue growth. 10.7%; 3-period range -14.4% to -3.2%. Revenue growth: 10.7%, above normal range; 3-period mean -9.4%, range -14.4%--3.2%. | 8.0% | -10.5% | -20.0% | -3.2% | -14.4% | -19.2% | Chart
|
| EBITDA | -$8.3m | $18.4m | -$8.1m | $4.4m | -$2m | — | $3.5m | $2.5m | Chart |
| EBITDA margin % | -7.8% | 20.7% | -19.2% | 5.5% | -5.0% | — | 3.6% | 5.1% | Chart |
| PBT | -$11.2m | $18.6m | -$8.1m | $4.9m | -$1.6m | -$0.6m | $2.6m | $1.3m | Chart |
| PBT growth % | — | 279.6% | — | — | — | — | 30.0% | -70.5% | Chart |
| NPAT | -$11.4m | $18.2m | -$8.1m | $4.6m | -$1.7m | -$0.8m | $2.2m | $1m | Chart |
| NPAT growth % | — | 295.7% | — | — | — | — | 29.4% | -76.7% | Chart |
| Operating cash flow | -$8.3m | $15.7m | -$21.8m | -$27.3m | -$15.8m | -$1.8m | -$2.9m | -$1.4m | Chart |
| OCF / EBITDA % | 98.9% | 85.5% | 269.4% | -616.6% | 806.6% | — | -83.9% | -55.2% | Chart |
| FCF pre-lease | -$14m | $10.2m | -$25m | -$31.3m | -$17.8m | -$3.5m | -$5.8m | -$3m | Chart |
| DPS | 0.0c | 0.0c | — | — | — | — | — | — | Chart |
| ROE % | -18.8% | 25.2%Outside range high roe. 25.2%; 3-period range -2% to 8.5%. ROE: 25.2%, above normal range; 3-period mean 4.2%, range -2.0%-8.5%. | -17.6% | 8.5% | -3.4% | -2.0% | 5.9% | 2.7% | Chart
|
| Net debt | -$22m | — | — | — | — | — | — | — | — |
| Net debt / EBITDA | 2.64x | — | — | — | — | — | — | — | — |
| Debtor days | 46Outside range low debtor days. 46d; 3-period range 47d to 82d. Debtor days: 46.2 days, below normal range; 3-period mean 58.8 days, range 46.7 days-81.9 days. | 48 | 50 | 45 | 51 | 82 | 47 | 46 | Chart
|
| Inventory days | 99Outside range low inventory days. 99d; 4-period range 104d to 225d. Inventory days: 99.3 days, below normal range; 4-period mean 144.4 days, range 104.2 days-224.6 days. | 116 | 154 | 133 | 99 | 225 | 104 | 79 | Chart
|
| Total assets | $99m | $107.6m | $80m | $94.9m | $85m | $77.3m | $78.9m | $75.9m | Chart |
Reference: annolyse.ai/companies/brw
Note: Figures are shown as reported. Half-year and full-year absolute values are not directly comparable. Growth rates and ratios are the meaningful comparison across mixed periods.
These charts use verified published filing periods only. Gaps are not interpolated, and mixed half-year/full-year histories are split into separate series.
Reported revenue across covered periods.
Like-period revenue growth where comparable.
Company-specific earnings measure where disclosed.
EBITDA-equivalent margin where revenue and earnings are source-backed.
Statutory profit after tax.
Cash generated from operations.
Additional filing-backed metrics for this company. Each point links to the relevant published briefing.
Operating cash flow less capex before leases.
Return on equity.
Borrowings less cash; negative values indicate net cash.
Dividend per share declared for the period.
Receivables days where the working-capital inputs are source-backed.
Inventory days where the working-capital inputs are source-backed.
Per-period working-capital absorption or release, from the same published history. Positive values are working-capital build; negative values are release.
The setup & the reality
The latest result is checked against what the prior briefing said to watch.
Historical setup
Previous analysisFY25Result releasedAnnolyse analysis published
From NPAT up 295.7% but gross margin collapsed 1,091bps to 13.4%
No FY26 targets, forward-work disclosure, or guidance accompany the release, so the result has to be judged on its own shape. The interim context is striking: HY25 NPAT was -NZ$8.1m, implying second-half NPAT of NZ$26.4m and second-half operating cash flow of NZ$37.5m on second-half revenue of NZ$46.8m. A swing of that magnitude on a 47.4%/52.6% revenue split is not consistent with a normal seasonal pattern and is more readily explained by a discrete second-half event recognised below gross profit.
The prior-year release flagged a "return to dividends by 2026", but the current release shows no declared dividend, leaving the cadence of any resumption unconfirmed.
Open questions
This briefing cannot assess the specific composition of the non-recurring items between gross profit and PBT because the supplied excerpts do not itemise the relevant lines.
Primary issuer documents used for the FY26 briefing. Document labels are preserved from the publication record; Annolyse does not relabel every financial report as an annual report.
Bremworth Limited Annual Report 2026; selected FY26 column
FY26 / financial reportBremworth Limited Annual Report 2026; selected FY25 column
FY25 / financial reportPeer context
These companies share a broad sector but may not be direct peers. Compare them only where the underlying measures are genuinely comparable.
Archive
The full chronological archive contains every published result briefing.
FY26 · Released 31 August 2026
Revenue increased, but insurance differences and negative operating cash flow qualify the earnings comparison.
FY25 · Released 1 September 2025
PBT of NZ$18.6m exceeds gross profit of NZ$11.9m, signalling one-off items rather than core trading drove the headline result.
HY25 · Released 28 February 2025
Revenue rose 8.0% but a deliberate $14.5m woollen yarn pre-build drove a $21.8m operating cash outflow and widened the loss to $8.1m.
FY24 · Released 29 August 2024
FY24 NPAT of $4.6m sits against an insurance-boosted FY23 base, inventory days extended to 133, and cash fell $7.7m to $31.6m.
HY24 · Released 29 February 2024
A 20.0% revenue decline pushed Bremworth to a NZD 1.7m loss while inventory days climbed roughly 20 days, draining cash before a capital injection.
FY23 · Released 1 March 2023
Reported PBT moved to a loss; the comparison requires the disclosed amounts and accounting bases.
Get the next Bremworth result briefing and five-year history updates by email.